Food News and Research

RSS

FDA approves Medtronic's Protecta implantable defibrillators

Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

29 Mar 2011

Burger that needs an hour of exercise to burn off

Fast food chain KFC is set to launch its latest fat-and-sodium laden creation that has done away with the most basic of burger ingredients - the bun. The ‘Double Down’ instead has bacon, sauce and two slices of melted cheese between two pieces of deep fried chicken. The figures stand thus;

28 Mar 2011

Inflammatory bowel disease in children - Delays in diagnosis common

Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children’s Center.

28 Mar 2011

Review questions diagnostic value of MRI scans to detect rupture of silicone breast implants

The U.S. Food and Drug Administration currently recommends regular follow-up magnetic resonance imaging (MRI) scans for women with silicone breast implants. But a new review shows significant flaws in the evidence supporting this recommendation, reports the March issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

28 Mar 2011

GTCR completes Sterigenics acquisition

GTCR, a leading private equity firm, today announced it has successfully completed the acquisition of Sterigenics International, Inc., the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications, from Silverfleet Capital and PPM America Capital Partners.

28 Mar 2011

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.

28 Mar 2011

A.P. Pharma fourth quarter revenue decreases to $1.6 million

A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended December 31, 2010 and provided a corporate update.

28 Mar 2011

RDY introduces Levocetirizine tablets in the U.S. market

Dr. Reddy's Laboratories has launched Levocetirizine tablets, a bioequivalent generic version of Xyzal tablets in the US market. The United States Food & Drug Administration approved Dr. Reddy's ANDA for Levocetirizine tablets on February 24, 2011.

28 Mar 2011

U.S. FDA approves Yervoy to treat patients with late-stage melanoma

The U.S. Food and Drug Administration today approved Yervoy to treat patients with late-stage melanoma, the most dangerous type of skin cancer.

28 Mar 2011

CHPA issues statement in response to anti-consumer law on cold and allergy drugs

The Consumer Healthcare Products Association today issued the following statement in response to passage of Senate Bill 437: "Legislation sponsored by Senator Percy Malone and now signed into law places new, onerous burdens on Arkansas families and makes it more difficult for those with common colds and allergies, even basic aches and pains, to get the medications they need. Unfortunately, Senate Bill 437 falls short of the common-sense approach Arkansans expect from their leaders."

28 Mar 2011

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

28 Mar 2011

Financial Times examines rise in public, private sector global partnerships for aid delivery

"New models of financing and delivering development programmes are bringing far-reaching changes to the international public sector," with " traditional government-to-government transactions … giving way to complex networks of partners - some of them from the private sector - to provide everything from antiretroviral drugs and girls' education to emergency food supplies," the Financial Times reports in a piece that explores why such changes are taking place and their implications for future funding.

28 Mar 2011

Antioxidants in walnuts can reduce risk of heart disease

A new scientific study positions walnuts in the No. 1 slot among a family of foods that lay claim to being among Mother Nature's most nearly perfect packaged foods: Tree and ground nuts.

28 Mar 2011

Panax ginseng, saffron and yohimbine can boost human sexual function

Looking to spice up your sex life? Try adding ginseng and saffron to your diet. Both are proven performance boosters, according to a new scientific review of natural aphrodisiacs conducted by University of Guelph researchers.

28 Mar 2011

Nano-bricks may improve plastic food packaging strength and performance

Scientists are reporting on a new material containing an ingredient used to make bricks that shows promise as a transparent coating for improving the strength and performance of plastic food packaging.

28 Mar 2011

BMY receives FDA approval for YERVOY to treat metastatic melanoma

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration approved YERVOY 3 mg/kg for the treatment of patients with unresectable or metastatic melanoma.

28 Mar 2011

APP voluntarily recalls Irinotecan Hydrochloride Injection for precautionary measure

APP Pharmaceuticals, Inc., announced today that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal cancer.

28 Mar 2011

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.

28 Mar 2011

FDA approves ipilimumab to treat metastatic melanoma

The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.

28 Mar 2011

Decline of obesity in pre-school kids: Study

According to a new study from the Deakin University, obesity in Victorian pre-school children has dropped. Results have shown that rates of obese and overweight toddlers fell by more than 3 per cent for three-and-a-half year olds, down from 18.5 per cent to 15.4 per cent. For two-year-olds rates have dropped 1 per cent to 12.4 per cent.

27 Mar 2011